BET-IN-19 (Compound 146) is a BET inhibitor. BET-IN-19 inhibits hlL-6 mRNA transcription (IC50 0.3 uM), and c-myc activity in human AML MV4-11 cell (IC50 0.3 uM)BET-IN-19 inhibits tetra-acetylated histone H4 binding to BRD4 bromodomain 1 (IC50 0.3 uM)[1].
Molecular Weight:
333.39
Purity:
99.74
CAS Number:
[1643947-30-1]
Formula:
C19H19N5O
Target:
Epigenetic Reader Domain
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted